High Court's Amgen Ruling Could Stymie Securities Classes
In agreeing Monday to hear Amgen Inc.'s appeal of a recent Ninth Circuit decision, the Supreme Court moved to resolve a glaring split between the circuits and establish when materiality needs...To view the full article, register now.
Already a subscriber? Click here to view full article